Acute myocardial infarction. An updated protocol for thrombolytic therapy

Area of Science:

• Cardiology
• Emergency Medicine
• Health Services Research

Background:

• Acute myocardial infarction (heart attack) is a time-sensitive medical emergency.
• Intravenous thrombolytic therapy is a critical treatment for heart attacks.
• Current treatment protocols often involve significant pre-hospital and in-hospital delays, limiting patient access to this therapy.

Purpose of the Study:

• To highlight the underutilization of intravenous thrombolytic therapy in acute myocardial infarction.
• To identify logistical delays as a primary barrier to timely treatment.
• To advocate for streamlined and regularly updated protocols to improve therapy utilization.

Main Methods:

• This study is a recommendation based on the analysis of current treatment logistics for acute myocardial infarction.
• It emphasizes the need for protocol optimization rather than presenting new clinical trial data.

Main Results:

• A small percentage of acute myocardial infarction patients benefit from intravenous thrombolytic therapy.
• Logistical delays in pre-hospital and in-hospital care are significant barriers.
• Current protocols are insufficient to ensure timely administration of this time-dependent treatment.

Conclusions:

• Streamlined protocols are essential for the routine utilization of intravenous thrombolytic therapy.
• Regular updates to these protocols are necessary to adapt to evolving medical practices and ensure optimal patient care.
• Improving access to timely thrombolytic therapy can significantly improve outcomes for patients with acute myocardial infarction.